Eukaryotic proteins with carboxyl-terminal Ca
1a
2 motifs undergo three posttranslational processingreactions-prenylation, endoproteolysis, and carboxymethylation. Two genes in yeast encoding Ca
1a
2Xendoproteases,
AFC1 and
RCE1, have been identified. Rce1p is solely responsible for proteolysis ofyeast Ras proteins. When proteolysis is blocked, localization of Ras2p to the outer membrane isimpaired. The mislocalization of undermodified Ras in the cell suggests that Rce1p is an attractive target for cancer therapeutics. A biotinylated, farnesylated Ca
1a
2X peptide [(1-
N-biotinyl-(13-
N-succinimidyl-(
S-(
E,E-farnesyl)-
L-cysteinyl)-
L-valinyl-
L-isoleucinyl-
L-alanine))-4,7,10-trioxatridecanediamine]
1 containing a poly(ethylene glycol) linker was prepared by solid-phase synthesisfor use in an assay for Ca
1a
2X endoprotease activity that relies on the strong affinity of avidin
forbiotin. The peptide was radiolabeled in the penultimate step of the synthesis by cleavage of thebiotinylated, farnesylated Ca
1a
2 precursor from Kaiser's oxime resin with [
14C]-
L-alanine methyl ester.[
14C]
1 was a good substrate for yRce1p with
KM = 1.3 ± 0.3
M. Analysis of the carboxyl terminalproducts by reverse phase HPLC confirmed that VIA was the only radioactive fragment released uponincubation of [
14C]
1 with a yeast membrane preparation of recombinant yRce1p. The solid-phasemethodology developed using Kaiser's benzophenone oxime resin to synthesize [
14C]
1 should begenerally applicable for peptides containing sensitive side chains. In addition, introduction of theradiolabeled unit at the end of the synthesis mostly circumvents problems associated with handlingradioactive materials.